Twitxy Saved

colm leonard

@LeonardColm

NHS Consultant Chest Physician; Honorary Professor of Respiratory Medicine; Chief Clinical Officer INFEX Therapeutics: AMR & sustainable antimicrobial pipeline
United Kingdom Joined July 2019
777 Following 289 Followers 108 Posts

Latest posts 5

colm leonard @LeonardColm
Very excited to work with Asian ADVANCE-ID network to plan clinical trials of our novel metallo-beta-lactamase (MBL) inhibitor, MET-X. Antimicrobials targeting MBL mechanism of Gram negative bacterial resistance to antibiotics is key gap in pipeline. @davidantibiotic @INFEX_TX
Infex agrees collaboration with Asian clinical trials network, ADVANCE-ID

Memorandum of Understanding signed to investigate hospital-acquired drug-resistant infections in Asia:
infextx.com/infex-agrees-c…
View quoted post on X
1 replies 6 reposts 15 likes 754 views View on X
colm leonard @LeonardColm
Excited to share our licensing deal in India for clinical development of MET-X our novel metallobetalactamase (MBL) inhibitor. MBL mechanism of resistance is an enormous problem in India & SE Asia & a rising problem EU & USA. MBL mechanism is a key pipeline priority for WHO
Infex signs exclusive license agreement with Venus Remedies Ltd to advance MET-X through clinical development and commercialisation in India:
infextx.com/infex-signs-ex…
View quoted post on X